[HTML][HTML] Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers

CEM Thornton, J Hao, PP Tamarapu, I Landa - Cancers, 2022 - mdpi.com
… advanced thyroid tumors. … promoter mutations. We also show that TERT expression is more
dependent on the MAPK signaling pathway in thyroid cells without TERT promoter mutations. …

[PDF][PDF] TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance

T Yabuta, M Matsuse, M Hirokawa, S Yamashita… - Thyroid, 2017 - researchgate.net
… for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer now … promoter
mutations was recently reported to be associated with poor outcomes of clinical papillary thyroid

[PDF][PDF] Low prevalence of somatic TERT promoter mutations in classic papillary thyroid carcinoma

MJ Jeon, WG Kim, S Sim, S Lim… - Endocrinology and …, 2016 - synapse.koreamed.org
… different thyroid cancer cells from different origins to evaluate TERT promoter mutations.
BCPAP cells originating from PTC presented the CC228229TT TERT promoter mutation (Fig. 1A…

[HTML][HTML] Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer

M Xing - BMC medicine, 2016 - Springer
… alone in FTC [30], similar to the coexistence of BRAF V600E mutation with TERT promoter
mutations that is associated with sharply increased aggressive clinicopathological behavior, …

[HTML][HTML] Deep Learning Prediction of TERT Promoter Mutation Status in Thyroid Cancer Using Histologic Images

J Kim, S Ko, M Kim, NJY Park, H Han, J Cho, JY Park - Medicina, 2023 - mdpi.com
… of thyroid cancer patients. Materials and Methods: In this study, we evaluate TERT promoter
mutation status in thyroid cancer … resected thyroid cancers with TERT promoter mutations (…

Quantitative assessment of promoter methylation profiles in thyroid neoplasms

MO Hoque, E Rosenbaum, WH Westra… - The Journal of …, 2005 - academic.oup.com
… The only marker that we found to be significantly hypermethylated in thyroid cancers compared
with benign thyroid tumors was RAR-β2. The cutoff we chose identified 22% of papillary …

[HTML][HTML] BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients

J Sun, J Zhang, J Lu, J Gao, X Ren, L Teng, H Duan… - PLoS …, 2016 - journals.plos.org
… for TERT promoter mutations inhuman tumorigenesis. … promoter mutations in thyroid cancers;
these mutations are particularly prevalent in aggressive thyroid cancers and BRAF mutation

[HTML][HTML] Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: Implications in precision oncology—A narrative review

X Yuan, T Liu, D Xu - Annals of Translational Medicine, 2020 - ncbi.nlm.nih.gov
… between the TERT promoter mutation and disease malignancy … of studies of TERT promoter
mutations in TC and underscore … Finally, the targeting of TERT promoter mutations and the …

[HTML][HTML] Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma

R Liu, Y Li, W Chen, J Cong, Z Zhang… - Oncology …, 2020 - spandidos-publications.com
… Therefore, the significance of TERT promoter mutations in … of BRAF and TERT promoter
mutations were analyzed in … and treatment of thyroid nodules and differentiated thyroid cancer (31…

Significance of telomerase reverse-transcriptase promoter mutations in differentiated thyroid cancer

HF Lai, CY Kuo, SP Cheng - Formosan Journal of Surgery, 2021 - journals.lww.com
… telomerase, and TERT promoter mutations are enriched in advanced thyroid cancer. In this
study, … biology of differentiated thyroid cancer harboring TERT promoter mutations in Taiwan. …